GPLB Green Planet Bioengineering Co., Ltd.
Fundamentals / CIK 0001392449 / USDGreen Planet Bioengineering Co., Ltd. reported $0 in total assets and a net loss of $42K through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open GPLB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-- Operating profit
-
Net Income FY 2025-$42K GAAP bottom line
-
Diluted EPS FY 2025-$0.00 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2019$0 Total debt: --
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Interest Expense | $0 | $0 | $300 | $0 | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$36K | -$36K | -$48K | -$33K | -- | -- | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$36K | -$36K | -$48K | -$33K | -$33K | -$34K | -$25K | -$40K | -$34K | -$36K |
| Basic EPS | -- | -- | -- | -- | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | -- | -- | -- | -- | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M |
| Diluted Shares Outstanding | 20.0M | 20.0M | 20.0M | -- | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Interest Expense | -- | -- | $150 | -- | -- | -- | -- | -- |
| Income Before Tax | -$8.4K | -$5.9K | -$11K | -$16K | -$8.6K | -$4.1K | -$6.8K | -$13K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$8.4K | -$5.9K | -$11K | -$16K | -$8.6K | -$4.1K | -$6.8K | -$13K |
| Diluted EPS | $0.00 | $0.00 | -- | -- | $0.00 | $0.00 | $0.00 | -- |
| Diluted Shares Outstanding | 20.0M | 20.0M | 20.0M | -- | 20.0M | 20.0M | 20.0M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2019-09-30 | 2019-06-30 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash & Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | -- | -- | $0 | -- | -- | -- | $0 | -- |
| Total Non-Current Assets | -- | -- | $0 | -- | -- | -- | $0 | -- |
| Total Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Liabilities | -- | -- | $258K | -- | -- | -- | -- | -- |
| Total Non-Current Liabilities | -- | -- | $0 | -- | -- | -- | -- | -- |
| Total Liabilities | $284K | $272K | $258K | $245K | $233K | $226K | $217K | $207K |
| Common Stock | $20K | $20K | $20K | $20K | $20K | $20K | $20K | $20K |
| Retained Earnings | -$913K | -$901K | -$887K | -$874K | -$863K | -$856K | -$847K | -$837K |
| Total Stockholders' Equity | -$284K | -$272K | -$258K | -$245K | -$233K | -$226K | -$217K | -$207K |
| Total Equity | -$284K | -$272K | -$258K | -$245K | -$233K | -$226K | -$217K | -$207K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$36K | -$36K | $48K | $33K | -$33K | -$34K | $64K | $8.4K | $12K | $12K |
| Change in Payables | -- | -- | -- | $0 | $0 | -$214 | $214 | $0 | $0 | $0 |
| Operating Cash Flow | -$37K | -$35K | -$43K | -$33K | -$33K | -$34K | -$37K | -$40K | $0 | $0 |
| Investing Cash Flow | -- | $35K | $43K | $0 | -- | -- | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $37K | $35K | $43K | $33K | $33K | $34K | $37K | $40K | $0 | $0 |
| Net Change in Cash | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$8.4K | -$5.9K | -$11K | -$16K | -$8.6K | -$4.1K | -$6.8K | -$13K |
| Operating Cash Flow | -$8.4K | -$13K | -$17K | -$17K | -$6.6K | -$6.0K | -$6.9K | -$11K |
| Investing Cash Flow | -- | $0 | $0 | -- | $0 | $0 | $0 | $35K |
| Financing Cash Flow | $8.4K | $13K | $17K | $17K | $6.6K | $6.0K | $6.9K | $11K |
| Net Change in Cash | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| 10Y Net Income / Share Growth | -- | -- | -- | -- | -- | -104.2% | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.